TET vs. VCT, SCPA, ESNT, ZTF, SYNT, IOF, HAYD, WCH, ITX, and DCTA
Should you be buying Treatt stock or one of its competitors? The main competitors of Treatt include Victrex (VCT), Scapa Group (SCPA), Essentra (ESNT), Zotefoams (ZTF), Synthomer (SYNT), Iofina (IOF), Haydale Graphene Industries (HAYD), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), and Directa Plus (DCTA). These companies are all part of the "specialty chemicals" industry.
Treatt vs. Its Competitors
Treatt (LON:TET) and Victrex (LON:VCT) are both small-cap basic materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation.
Treatt has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Victrex has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500.
Victrex has a net margin of 10.81% compared to Treatt's net margin of 7.88%. Treatt's return on equity of 8.09% beat Victrex's return on equity.
Treatt pays an annual dividend of GBX 0.08 per share and has a dividend yield of 0.0%. Victrex pays an annual dividend of GBX 0.60 per share and has a dividend yield of 0.1%. Treatt pays out 45.9% of its earnings in the form of a dividend. Victrex pays out 175.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Treatt presently has a consensus price target of GBX 256.67, indicating a potential downside of 5.11%. Victrex has a consensus price target of GBX 822, indicating a potential upside of 19.48%. Given Victrex's higher probable upside, analysts clearly believe Victrex is more favorable than Treatt.
42.1% of Treatt shares are held by institutional investors. Comparatively, 75.5% of Victrex shares are held by institutional investors. 4.1% of Treatt shares are held by insiders. Comparatively, 4.1% of Victrex shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
In the previous week, Treatt had 1 more articles in the media than Victrex. MarketBeat recorded 1 mentions for Treatt and 0 mentions for Victrex. Victrex's average media sentiment score of 1.02 beat Treatt's score of 0.75 indicating that Victrex is being referred to more favorably in the news media.
Victrex has higher revenue and earnings than Treatt. Treatt is trading at a lower price-to-earnings ratio than Victrex, indicating that it is currently the more affordable of the two stocks.
Summary
Victrex beats Treatt on 11 of the 18 factors compared between the two stocks.
Get Treatt News Delivered to You Automatically
Sign up to receive the latest news and ratings for TET and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TET and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:TET) was last updated on 9/29/2025 by MarketBeat.com Staff
Free TET Stock Alerts